Similarly, in NSCLC, the lncRNA TNK2-AS1 can also bind to STAT3 to inhibit its degradation, thus activating the STAT3 signaling pathway and promoting tumor progression and angiogenesis. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.